银杏黄酮苷与复方丹参片治疗冠心病心绞痛疗效比较

目的：比较银杏黄酮苷(舒血宁片)与复方丹参片治疗冠心病心绞痛的疗效。方法：68例冠心病心绞痛患者随机分为，治疗组38例，口服银杏黄酮苷2片，tid；对照组30例，口服复方丹参片3片，tid。两组疗程均为4周，治疗前后观察临床症状、心电图、心功能、血液流变学、硝酸甘油用量及不良反应。结果：治疗组在临床症状及心电图、心功能及血液流变学的改善、硝酸甘油停减率方面均优于对照组(P＜0.05)，无明显不良反应。结论：银杏黄酮苷治疗心绞痛安全有效，优于复方丹参片。

A Comparison of Effects of Ginkgo Biloba Flavonal Glyco and Compound Salvia Miltiorrhiza Tablets in Treating Patients with Angina

Objective:To compare the therapeutic effects of ginkgo biloba flavonal glyco and compound salvia miltiorrhiza tablets in treating patients with angina. Method:68 patients were divided randomly into study group(n=38, ginkgo biloba flavonal glyco, 2 tablets, tid, po) and control group(n=30, compound salvia miltiorrhiza, 3 tablets, tid, po). Before and 4 weeks after the treatment, the clinical symptoms, electrocardiograms, cardiac functions, hemorheology, dosage of nitroglycerin and the adverse effects were observed. Results:The study group had better therapeutic effects in improving clinical symptoms(P<0.05), electrocardiograms, cardiac functions and hemorheology(P<0.05); and needed a smaller dosage of nitroglycerin than the control group(P<0.05). There were no obvious adverse effects in both groups. Conclusion:Ginkgo biloba flavonal glyco is safe and efficient in the therapy of patients with angina and it is superior to compound salvia miltiorrhiza.